A meta-analysis of the efficacy of adding immune checkpoint inhibitors to neoadjuvant chemotherapy against triple-negative breast cancer

被引：0
|
作者：
Li, Y. [1 ]
Xing, L. [1 ]
Yin, X. [1 ]
Li, H. [1 ]
Ren, G. [1 ]
机构：
[1] Chongqing Med Univ, Affiliated Hosp 1, Dept Endocrine & Breast Surg, Chongqing, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.03.082
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
68P
引用
收藏
页码：S50 / S51
页数：2
相关论文
共 50 条
  • [41] Platinum-based chemotherapy in triple-negative breast cancer: A meta-analysis
    Liu, Miao
    Mo, Qin-Guo
    Wei, Chang-Yuan
    Qin, Qing-Hong
    Huang, Zhen
    He, Jie
    ONCOLOGY LETTERS, 2013, 5 (03) : 983 - 991
  • [42] A Bayesian network meta-analysis of the efficacy of targeted therapies and chemotherapy for treatment of triple-negative breast cancer
    Chen, Huihui
    Lu, Wei
    Zhang, Yixin
    Zhu, Xuan
    Zhou, Jiaojiao
    Chen, Yiding
    CANCER MEDICINE, 2019, 8 (01): : 383 - 399
  • [43] Neoadjuvant Immune-Checkpoint Blockade in Triple-Negative Breast Cancer: Current Evidence and Literature-Based Meta-Analysis of Randomized Trials
    Marinelli, Daniele
    Mazzotta, Marco
    Pizzuti, Laura
    Krasniqi, Eriseld
    Gamucci, Teresa
    Natoli, Clara
    Grassadonia, Antonino
    Tinari, Nicola
    Tomao, Silverio
    Sperduti, Isabella
    Sanguineti, Giuseppe
    Botticelli, Andrea
    Fabbri, Agnese
    Botti, Claudio
    Ciliberto, Gennaro
    Barba, Maddalena
    Vici, Patrizia
    CANCERS, 2020, 12 (09) : 1 - 13
  • [44] Platinum is essential in neoadjuvant treatment of triple-negative breast cancer: a network meta-analysis
    Li, Junjie
    Chen, Li
    Tan, Wei
    Qi, Fang
    Zhang, Yang
    Wang, Zhonghua
    Shao, Zhimin
    CANCER BIOLOGY & MEDICINE, 2022, 19 (05) : 742 - 754
  • [45] Neoadjuvant therapy in triple-negative breast cancer: A systematic review and network meta-analysis
    Lin, Ying-Yi
    Gao, Hong-Fei
    Yang, Xin
    Zhu, Teng
    Zheng, Xing-xing
    Ji, Fei
    Zhang, Liu-Lu
    Yang, Ci-Qiu
    Yang, Mei
    Li, Jie-Qing
    Cheng, Min-Yi
    Wang, Kun
    BREAST, 2022, 66 : 126 - 135
  • [46] Platinum is essential in neoadjuvant treatment of triple-negative breast cancer: a network meta-analysis
    Junjie Li
    Li Chen
    Wei Tan
    Fang Qi
    Yang Zhang
    Zhonghua Wang
    Zhimin Shao
    Cancer Biology & Medicine, 2022, 19 (05) : 742 - 754
  • [47] Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
    Silver, Daniel P.
    Richardson, Andrea L.
    Eklund, Aron C.
    Wang, Zhigang C.
    Szallasi, Zoltan
    Li, Qiyuan
    Juul, Nicolai
    Leong, Chee-Onn
    Calogrias, Diana
    Buraimoh, Ayodele
    Fatima, Aquila
    Gelman, Rebecca S.
    Ryan, Paula D.
    Tung, Nadine M.
    De Nicolo, Arcangela
    Ganesan, Shridar
    Miron, Alexander
    Colin, Christian
    Sgroi, Dennis C.
    Ellisen, Leif W.
    Winer, Eric P.
    Garber, Judy E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (07) : 1145 - 1153
  • [48] Immune checkpoint inhibitors in first-line therapies of metastatic or early triple-negative breast cancer: a systematic review and network meta-analysis
    Liang, Xueyan
    Chen, Xiaoyu
    Li, Huijuan
    Li, Yan
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [49] A meta-analysis of the effect and safety of platinum-based neoadjuvant chemotherapy in treatment of resectable triple-negative breast cancer
    Feng, Wuna
    He, Yujing
    Xu, Jingsi
    Zhang, Hongya
    Si, Yuexiu
    Xu, Jiaxuan
    Li, Shengzhou
    ANTI-CANCER DRUGS, 2022, 33 (01) : E52 - E60
  • [50] How far along is precision oncology with immune checkpoint inhibitors for triple-negative breast cancer? A meta analysis and position paper
    Sarfraz, A.
    Sarfraz, Z.
    ANNALS OF ONCOLOGY, 2022, 33 (08) : S1391 - S1391
12345